dobutamine-injection, Dobutrex (cont.)
PRECAUTIONS: Tell your doctor if you have: liver disease, any allergies, pheochromocytoma, irregular heartbeat/arrhythmias. This medication should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your doctor. It is not known whether this medication is excreted into breast milk. Consult your doctor before breast-feeding to review risks.
DRUG INTERACTIONS: Tell your doctor of any nonprescription or prescription medicines you take, especially of: antidepressants (esp. tricyclics), maprotiline, beta-blockers, digoxin, reserpine, MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, selegiline, tranylcypromine), methyldopa, guanethidine. Dobutamine cannot be mixed with alkaline solutions such as sodium bicarbonate. Several other advisories apply to mixing or administering this medication. The pharmacist can assist with any questions or further information. Do not start or stop any medicine without doctor or pharmacist approval.
OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include loss of appetite, nausea, vomiting, tremor, headache, shortness of breath, and chest pain.
NOTES: Blood tests, particularly potassium and kidney function, are generally performed during treatment, as well as assessment of your heart and lung function and blood pressure.
MISSED DOSE: Follow instructions from your health care provider if you have problems with your IV infusion, or if treatment is interrupted.
STORAGE: Dobutamine diluted in IV solutions should be used within 24 hours. Freezing should be avoided. Refrigerate IV solutions until use. Pink discoloration is harmless if medication is used within proper time limits. Store away from moisture and light.
MEDICAL ALERT: Your condition can cause complications in a medical emergency. For enrollment information call MedicAlert at 1-800-854-1166 (USA), or 1-800-668-1507 (Canada).
Last Editorial Review: 3/2/2005
Back to Medications Index
Get the latest health and medical information delivered direct to your inbox FREE!